Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.5500
0.00 (0.00%)
Aug 6, 2026, 2:05 PM EST
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 28.51 million as of August 10, 2026. Its market cap has decreased by -31.25% in one year.
Market Cap
28.51M
Enterprise Value
21.23M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
ChartMarket Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 28.51M, an increase of 104.30%. That is a compound annual growth rate of 17.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 28.51M | -15.38% |
| Dec 31, 2025 | 33.69M | 22.03% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Microbix Biosystems | 39.95M |
| Sona Nanotech | 38.32M |
| Telescope Innovations | 34.76M |
| Medicenna Therapeutics | 34.61M |
| Resverlogix | 32.66M |
| Quantum BioPharma | 30.78M |
| Defence Therapeutics | 30.32M |
| Sharp Therapeutics | 27.37M |